Residual translational and rotational errors after kV X-ray image-guided correction of prostate location using implanted fiducials

Strahlentherapie und Onkologie

Volumn 186, Issue 10, 2010, Pages 544-550

  Graf, Reinhold ^a   Boehmer, Dirk ^a   Budach, Volker ^a   Wust, Peter ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

kV image guided radiotherapy; Prostate fiducials; Safety margins

Indexed keywords

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DIAGNOSTIC ERROR; DIAGNOSTIC IMAGING; EVALUATION; FIDUCIAL; HUMAN; KILOVOLTAGE X RAY; MALE; PROSTATE; RADIOLOGICAL PARAMETERS; SAFETY; X RAY;

ALGORITHMS; COHORT STUDIES; CONTRAST MEDIA; FIDUCIAL MARKERS; HUMANS; MALE; PROSTATIC NEOPLASMS; PROSTHESES AND IMPLANTS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; TOMOGRAPHY, X-RAY COMPUTED; X-RAYS;

EID: 78650176721     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-010-2030-8     Document Type: Article

References (48)

1. Alonso-Arrizabalaga S, Brualla Gonzalez L, Rosello Ferrando JV, et al. Prostate planning treatment volume margin calculation based on the ExacTrac X-Ray 6D image-guided system: margins for various clinical implementations. Int J Radiat Oncol Biol Phys 2007;69:936-43. (Pubitemid 47418422)
2. Aubry JF, Beaulieu L, Girouard LM, et al. Measurements of intrafraction motion and interfraction and intrafraction rotation of prostate by three-dimensional analysis of daily portal imaging with radiopaque markers. Int J Radiat Oncol Biol Phys 2004;60:30-9. (Pubitemid 39165466)
3. Beaulieu L, Girouard LM, Aubin S, et al. Performing daily prostate targeting with a standard V-EPID and an automated radio-opaque marker detection algorithm. Radiother Oncol 2004;73:61-4. (Pubitemid 39304126)
4. Boda-Heggemann, Kohler FM, Wertz H, et al. Intrafraction motion of the prostate during an IMRT session: a fiducial-based 3D measurement with cone-beam CT. Radiat Oncol 2008;3:37.
5. Chung PW, Haycocks T, Brown T, et al. On-line aSi portal imaging of implanted fiducial markers for the reduction of interfraction error during conformal radiotherapy of prostate carcinoma. Int J Radiat Oncol Biol Phys 2004;60:329-34. (Pubitemid 39165501)
6. Cosgrove VP, Jahn U, Pfaender M, et al. Commissioning of a micro multi-leaf collimator and planning system for stereotactic radiosurgery. Radiother Oncol 1999;50:325-36. (Pubitemid 29207535)
7. De Boer HC, van Os MJ, Jansen PP, Heijmen BJ. Application of the No Action Level (NAL) protocol to correct for prostate motion based on electronic portal imaging of implanted markers. Int J Radiat Oncol Biol Phys 2005;61:969-83. (Pubitemid 40340892)
8. Eng TY, Luh JY, Thomas CR Jr. The efficacy of conventional external beam, three-dimensional conformal, intensity-modulated, particle beam radiation, and brachytherapy for localized prostate cancer. Curr Urol Rep 2005;6:194-209.
9. Enmark M, Korreman S, Nystrom H. IGRT of prostate cancer: is the margin reduction gained from daily IG time-dependent? Acta Oncol 2006;45: 907-14. (Pubitemid 44423139)
10. Fu W, Yang Y, Li X, et al. Dosimetric effects of patient rotational setup errors on prostate IMRT treatments. Phys Med Biol 2006;51:5321-31. (Pubitemid 44540134)
11. Ghadjar P, Gwerder N, Madlung A, et al. Use of gold markers for setup in image-guided fractionated high-dose-rate brachytherapy as a monotherapy for prostate cancer. Strahlenther Onkol 2009;185:731-5.
12. Ghilezan M, Jaffray D, Siewerdsen J, et al. Prostate gland motion assessed with cine magnetic resonance imaging (cine-MRI). Int J Radiat Oncol Biol Phys 2005;62:406-17. (Pubitemid 40704457)
13. Graf R, Wust P, Budach V, Bohmer D. Potentials of on-line repositioning based on implanted fiducial markers and electronic portal imaging in prostate cancer radiotherapy. Radiat Oncol 2009;4:13.
14. Henry AM, Wilkinson C, Wylie JP, et al. Trans-perineal implantation of radio-opaque treatment verification markers into the prostate: an assessment of procedure related morbidity, patient acceptability and accuracy. Radiother Oncol 2004;73:57-9. (Pubitemid 39304125)
15. International Commission on Radiation Units and Measurements. Prescribing, recording and reporting photon beam therapy. ICRU report 50. Bethesda: International Commission on Radiation Units and Measurements, 1993.
16. Kalz J, Sterzing F, Schubert K, et al. Dosimetric comparison of image guidance by megavoltage computed tomography versus bone alignment for prostate cancer radiotherapy. Strahlenther Onkol 2009;185:241-7.
17. Kotte AN, Hofman P, Lagendijk JJW, et al. Intrafraction motion of the prostate during external-beam radiation therapy: analysis of 427 patients with implanted fiducial markers. Int J Radiat Oncol Biol Phys 2007; 69:419-25. (Pubitemid 47380089)
18. Kupelian PA, Lee C, Langen KM, et al. Evaluation of image-guidance strategies in the treatment of localized prostate cancer. Int J Radiat Oncol Biol Phys 2008;70:1151-7. (Pubitemid 351296109)
19. Kupelian PA, Willoughby TR, Meeks SL, et al. Intraprostatic fiducials for localization of the prostate gland: monitoring intermarker distances during radiation therapy to test for marker stability. Int J Radiat Oncol Biol Phys 2005;62:1291-6. (Pubitemid 40982046)
20. Langen KM, Zhang Y, Andrews RD, et al. Initial experience with megavoltage (MV) CT guidance for daily prostate alignments. Int J Radiat Oncol Biol Phys 2005;62:1517-24. (Pubitemid 40982078)
21. Lauve AD, Siebers JV, Crimaldi AJ, et al. A dynamic compensation strategy to correct patient-positioning errors in conformal prostate radiotherapy. Med Phys 2006;33:1879-87. (Pubitemid 43830276)
22. Letourneau D, Martinez AA, Lockman D, et al. Assessment of residual error for online cone-beam CT-guided treatment of prostate cancer patients. Int J Radiat Oncol Biol Phys 2005;62:1239-46. (Pubitemid 40884440)
23. Linthout N, Verellen D, Tournel K, et al. Assessment of secondary patient motion induced by automated couch movement during on-line 6 dimensional repositioning in prostate cancer treatment. Radiother Oncol 2007;83:168-74. (Pubitemid 46776926)
24. Litzenberg DW, Balter JM, Hadley SW, et al.Influence of intrafraction motion on margins for prostate radiotherapy. Int J Radiat Oncol Biol Phys 2006;65:548-53.
25. McNair HA, Hansen VN, Parker CC, et al. A comparison of the use of bony anatomy and internal markers for offline verification and an evaluation of the potential benefit of online and offline verification protocols for prostate radiotherapy. Int J Radiat Oncol Biol Phys 2008;71:41-50. (Pubitemid 351491391)
26. Nairz O, Merz F, Deutschmann H, et al. A strategy for the use of image-guided radiotherapy (IGRT) on linear accelerators and its impact on treatment margins for prostate cancer patients. Strahlenther Onkol 2008;184: 663-7.
27. Noel C, Parikh PJ, Roy M, et al. Prediction of intrafraction prostate motion: accuracy of pre- and post-treatment imaging and intermittent imaging. Int J Radiat Oncol Biol Phys 2009;73:692-8.
28. Pinkawa M, Pursch-Lee M, Asadpour B, et al. Image-guided radiotherapy of prostate cancer. Strahlenther Onkol 2008;184:679-85.
29. Polat B, Guenther I, Wilbert J, et al. Intrafractional uncertainties in image- guided intensity-modulated radiotherapy (IMRT) of prostate cancer. Strahlenther Onkol 2008;184:668-73.
30. Poli ME, Parker W, Patrocinio H, et al. An assessment of PTV margin definitions for patients undergoing conformal 3D external beam radiation therapy for prostate cancer based on an analysis of 10,327 pretreatment daily ultrasound locations. Int J Radiat Oncol Biol Phys 2007;67:1430-7. (Pubitemid 46467152)
31. Poulsen PR, Muren LP, Hoyer M. Residual set-up errors and margins in on-line image-guided prostate localization in radiotherapy. Radiother Oncol 2007;85:201-6. (Pubitemid 350161000)
32. Remeijer P, Geerlof E, Ploeger L, et al. 3-D portal image analysis in clinical practice: an evaluation of 2-D and 3-D analysis techniques as applied to 30 prostate cancer patients. Int J Radiat Oncol Biol Phys 2000;46:1281-90. (Pubitemid 30139441)
33. Rijkhorst EJ, van Herk M, Lebesque JV, Sonke JJ. Strategy for online correction of rotational organ motion for intensity-modulated radiotherapy of prostate cancer. Int J Radiat Oncol Biol Phys 2007;69:1608-17. (Pubitemid 350116436)
34. Scarbrough TJ, Golden NM, Ting JY, et al. Comparison of ultrasound and implanted seed marker prostate localization methods: implications for image-guided radiotherapy. Int J Radiat Oncol Biol Phys 2006; 65:378-87.
35. Schallenkamp JM, Herman MG, Kruse JJ, Pisansky TM. Prostate position relative to pelvic bony anatomy based on intraprostatic gold markers and electronic portal imaging. Int J Radiat Oncol Biol Phys 2005;63: 800-11. (Pubitemid 41400069)
36. Soete G, Van de Steene J, Verellen D, et al. Initial clinical experience with infrared reflecting skin markers in the positioning of patients treated by conformal radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2002;52:694-8. (Pubitemid 34158731)
37. Soete G, Verellen D, Michielsen D, et al. Clinical use of stereoscopic X-ray positioning of patients treated with conformal radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2002;54:948-52.
38. Soete G, Verellen D, Tournel K, Storme G. Setup accuracy of stereoscopic X-ray positioning with automated correction for rotational errors in patients treated with conformal arc radiotherapy for prostate cancer. Radiother Oncol 2006;80:371-3. (Pubitemid 44397199)
39. Tsai CL, Wu JK, Wang CW, et al. Using cone-beam computed tomography to evaluate the impact of bladder filling status on target position in prostate radiotherapy. Strahlenther Onkol 2009;185:588-95.
40. Van den Heuvel F, Fugazzi J, Seppi E, Forman JD. Clinical application of a repositioning scheme, using gold markers and electronic portal imaging. Radiother Oncol 2006;79:94-100.
41. Van Herk M, Bruce A, Kroes G, et al. Quantification of organ motion during conformal radiotherapy of the prostate by three dimensional image registration. Int J Radiat Oncol Biol Phys 1995;33:1311-20.
42. Van Herk M, Remeijer P, Lebesque JV. Inclusion of geometric uncertainties in treatment plan evaluation. Int J Radiat Oncol Biol Phys 2002;52:1407-22. (Pubitemid 34296500)
43. Van Herk M, Remeijer P, Rasch, C, Lebesque JV. The probability of correct target dosage: dose-population histograms for deriving treatment margins in radiotherapy. Int J Radiat Oncol Biol Phys 2000;47:1121-35. (Pubitemid 30345614)
44. Van Herten YR, van de Kamer JB, van Wieringen N, et al. Dosimetric evaluation of prostate rotations and their correction by couch rotations. Radiother Oncol 2008;88:156-62.
45. Verellen D, Soete G, Linthout N, et al. Quality assurance of a system for improved target localization and patient setup that combines realtime infrared tracking and stereoscopic X-ray imaging. Radiother Oncol 2003;67:129-41. (Pubitemid 36570449)
46. Wertz H, Lohr F, Dobler B, et al. Dosimetric impact of image-guided translational isocenter correction for 3-D conformal radiotherapy of the prostate. Strahlenther Onkol 2007;183:203-10. (Pubitemid 46570757)
47. Wu J, Haycocks T, Alasti H, et al. Positioning errors and prostate motion during conformal prostate radiotherapy using on-line isocentre set-up verification and implanted prostate markers. Radiother Oncol 2001; 61:127-33. (Pubitemid 33016571)
48. Yan H, Yin F, Kim J. A phantom study on the positioning accuracy of the Novalis Body System. Med Phys 2003;30:3052-60. (Pubitemid 37553745)